US2013144065A1PendingUtilityA1
Semiconductor materials prepared from bridged bithiazole copolymers
Est. expiryAug 5, 2030(~4.1 yrs left)· nominal 20-yr term from priority
Inventors:Ashok Kumar MishraSubramanian VaidyanathanHiroyoshi NoguchiFlorian DoetzBo ZhuJohan Sebastian Basuki
H10K 10/46H10K 85/655H10K 85/657C07D 513/14C08G 2261/3243C08G 2261/3246C08G 2261/364C08G 2261/596C08G 2261/228C08G 2261/3223C08G 61/12C08G 2261/414C08G 2261/124C08G 2261/344C07D 495/04C08G 61/126C08G 61/124C07D 513/04C08G 2261/92C08G 2261/3327C08G 61/123C08G 2261/226H10K 85/113H10K 85/6576H10K 10/466H01L 51/0071H01L 51/0074
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides semiconducting compounds, oligomers and polymers of formula wherein A 1 and A 2 can be the same or different and are S or Se, E is selected from the group consisting of The compounds, oligomers and polymers of formula of formula (1) are suitable for use in electronic devices such as organic field effect transistors.
Claims
exact text as granted — not AI-modified1 . A compound of formula
wherein
A 1 and A 2 are independently S or Se,
E is selected from the group consisting of
wherein
R 1 and R 2 are independently H, halogen, —CN, C 1-30 -alkyl, C 2-30 -alkenyl, C 2-20 -alkynyl, C 3-10 -cycloalkyl, C 5-10 -cycloalkenyl, C 8-10 -cycloalkynyl, C 1-30 -haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, —X 1 —R 6 , —X 2 —Ar 1 , —X 2 —Ar 2 —Ar 1 , —X 2 —Ar 2 —R 7 or —X 2 —Ar 2 —Ar 3 —R 7 ,
wherein
X 1 is —O—, —[Z 1 —O] a —, —[O—Z 1 ] a —O—, —S—, —[Z 1 —S—] a —, —[S—Z 1 ] a —S—, —S(O), —C(O)—, —C(O)O—, —C(O)NR 8 —, C(O)S—, —O(CO)—, —S(CO)—, —NR 8 C(O)— or —NR 8 —,
wherein
Z 1 is C 1-6 -alkylene, C 2-6 -alkenylene or C 1-6 -haloalkylene,
a is an integer of from 1 to 10, and
R 8 is H, C 1-20 -alkyl, or —Z 2 —C 6-14 -aryl,
wherein
Z 2 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,
R 6 is C 1-30 -alkyl, C 2-30 -alkenyl or C 1-30 -haloalkyl,
X 2 is —Z 3 —O—Z 4 —, —Z 3 —S—Z 4 —, —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 9 , —C(O)S—, —O(CO)—, —S(CO)—, —NR 9 C(O)—, —NR 9 —, —Z 3 —SiR 9 2 —Z 4 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond,
wherein
Z 3 and Z 4 are independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and
R 9 is H, C 1-20 -alkyl, or —Z 5 —C 6-14 -aryl,
wherein
Z 5 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,
Ar 1 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 substituents R a , wherein R a is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,
Ar 2 and Ar 3 are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R b , wherein R b is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and
R 7 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl, C 1-20 -alkoxy, —X 3 —Ar 4 , —X 3 —Ar 5 —Ar 4 , —X 3 —Ar 5 —R 10 , or —X 3 —Ar 5 —Ar 6 —R 10 ,
wherein
X 3 is —Z 6 —O—Z 7 —, —Z 6 —S—Z 7 , —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 11 , —C(O)S—, —O(CO)—, —S(CO)—, —NR 11 C(O)—, —NR 11 —, —Z 6 —SiR 11 2 —Z 7 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond,
wherein
Z 6 and Z 7 are independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and
R 11 is H, C 1-20 -alkyl or —Z 8 —C 6-14 -aryl,
wherein
Z 8 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,
Ar 4 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R c , wherein R c is independently selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,
Ar 5 and Ar 6 at are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R d , wherein R d is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and
R 10 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl or C 1-20 -alkoxy,
R 3 , R 4 and R 5 are independently H, halogen, —CN, C 1-30 -alkyl, C 2-30 -alkenyl, C 2-20 -alkynyl, C 3-10 -cycloalkyl, C 5-10 -cycloalkenyl, C 8-10 -cycloalkynyl, C 1-30 -haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, —X 4 —R 12 , —X 5 —Ar 7 , —X 5 —Ar 8 —Ar 7 , —X 5 —Ar 8 —R 13 or —X 5 —Ar 8 —Ar 9 —R 13 ,
wherein
X 4 is —[Z 9 —O] b —, —[Z 9 —S—] b —, —S(O)—, —C(O)—, —C(O)O—, —C(O)NR 14 — or C(O)S—,
wherein
Z 9 is C 1-6 -alkylene, C 2-6 -alkenylene or C 1-6 -haloalkylene,
b is an integer of from 1 to 10, and
R 14 is H, C 1-20 -alkyl, or —Z 10 —C 6-14 -aryl,
wherein
Z 10 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,
R 12 is C 1-30 -alkyl, C 2-30 -alkenyl or C 1-30 -haloalkyl,
X 5 is —Z 11 —O—Z 12 , —Z 11 —S—Z 12 —, —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 15 , —C(O)S—, —Z 11 —SiR 15 2 —Z 12 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond,
wherein
Z 11 is C 1-6 -alkylene, C 2-6 -alkenylene or C 1-6 -haloalkylene,
Z 12 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and
R 15 is H, C 1-20 -alkyl, or —Z 13 —C 6-14 -aryl,
wherein
Z 13 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,
Ar 7 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R e , wherein R e is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,
Ar 8 and Ar 9 are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R f , wherein R f is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and
R 13 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl, C 1-20 -alkoxy, —X 6 —Ar 10 , —X 6 —Ar 11 —Ar 10 , —X 6 —Ar 11 —R 16 , or —X 6 —Ar 11 —Ar 12 —R 17 ,
wherein
X 6 is —Z 14 —O—Z 15 —, —Z 14 —S—Z 15 , —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 18 , —C(O)S—, —O(CO)—, —S(CO)—, —NR 18 C(O)—, —NR 18 —, —Z 14 —SiR 18 2 —Z 15 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond,
wherein
Z 14 and Z 15 are independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and
R 18 is H, C 1-20 -alkyl or —Z 16 —C 6-14 -aryl,
wherein
Z 16 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,
Ar 10 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R g , wherein R g is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,
Ar 11 and Ar 12 are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R h , wherein R h is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and
R 17 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl or C 1-20 -alkoxy,
R 19 is O or C(CN) 2 , and
R 20 and R 21 are independently R 22 or CN,
wherein R 22 has the same meaning as R 1 ,
G 1 and G 2 are independently phenylene or a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R i , wherein R i is selected from the group consisting of a halogen, a —CN, a —NO 2 , a OH, a C 1-30 -alkyl, a C 2-30 -alkenyl, a C 2-30 -alkynyl, a —Z 17 —O—C 1-30 -alkyl, a —Z 17 —S—C 1-30 -alkyl, a —Z 17 —C 3-10 -cycloalkyl, a —Z 17 —C 5-10 -cycloalkenyl, a —Z 17 —C 8-10 -cycloalkynyl, a —Z 17 —C 6-14 -aryl, a —Z 17 -monovalent 3 to 12 membered aliphatic heterocyclic residue and a —Z 17 -monovalent 5 to 14 membered aromatic heterocyclic residue,
wherein
C 1-30 -alkyl, C 2-30 -alkenyl, C 2-30 -alkynyl, C 3-10 -cycloalkyl, C 5-10 -cycloalkenyl, C 8-10 -cycloalkynyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents R j , wherein R j is selected from the group consisting of a halogen, a —CN, a —NO 2 , a *═O, a —OH, a —NH 2 , a —NH(C 1-20 -alkyl), a —N(C 1-20 -alkyl) 2 , a —N(C 1-20 -alkyl)-C 6-14 -aryl, a —N(C 6-14 -aryl) 2 , a —S(O) m H, a —S(O) m —C 1-20 -alkyl, a —S(O) 2 OH, a —S(O) m —OC 1-20 -alkyl, a —S(O) m —OC 6-14 -aryl, a —CHO, a —C(O)—C 1-20 -alkyl, a —C(O)—C 6-14 -aryl, a —C(O)OH, a —C(O)—OC 1-20 -alkyl, a —C(O)—OC 6-14 -aryl, a —C(O)NH 2 , a —C(O)NH—C 1-20 -alkyl, a —C(O)N(C 1-20 -alkyl) 2 , a —C(O)NH—C 6-14 -aryl, a —C(O)N(C 1-20 -alkyl)-C 6-14 -aryl, a —C(O)N(C 6-14 -aryl) 2 , a —C(S)NH 2 , —C(S)NH—C 1-20 -alkyl, a —C(S)N(C 1-20 -alkyl) 2 , a —C(S)N(C 6-14 -aryl) 2 , a —C(S)N(C 1-20 -alkyl)-C 6-14 -aryl, a —C(S)NH—C 6-14 -aryl, a —S(O) m NH 2 , a —S(O) m NH(C 1-20 -alkyl), a —S(O) m N(C 1-20 -alkyl) 2 , a —S(O) m NH(C 6-14 -aryl), a —S(O) m N(C 1-20 -alkyl)-C 6-14 -aryl, a —S(O) m N(C 6-14 -aryl) 2 , a SiH 3 , a SiH(C 1-20 -alkyl) 2 , a SiH 2 (C 1-20 -alkyl) and a Si(C 1-20 -alkyl) 3 ,
wherein m is an integer of 0, 1 or 2,
wherein C 3-10 -cycloalkyl, C 5-10 -cycloalkenyl, —C 8-10 -cycloalkynyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R k , wherein R k is selected from the group consisting of a C 1-20 -alkyl, a C 2-20 -alkenyl, a C 2-20 -alkynyl, a C 1-20 -alkoxy, a —S—C 1-20 -alkyl, and a C 1-20 -haloalkyl, and
Z 17 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,
L is C 6-24 -arylene or a bivalent 5 to 18 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R l , wherein R l is selected from the group consisting of a halogen, a —CN, a —NO 2 , a *═O, a OH, a *═C(C 1-30 -alkyl) 2 , a C 1-30 -alkyl, a C 2-30 -alkenyl, a C 2-30 -alkynyl, a —Z 18 —O—C 1-30 -alkyl, a —Z 18 —S—C 1-30 -alkyl, a —Z 18 —C 3-10 -cycloalkyl, a —Z 18 —C 5-10 -cycloalkenyl, a —Z 18 —C 8-10 -cycloalkynyl, a —Z 18 —C 6-14 -aryl, a —Z 18 -monovalent 3 to 12 membered aliphatic heterocyclic residue and a —Z 18 -monovalent 5 to 14 membered aromatic heterocyclic residue,
wherein
C 1-30 -alkyl, C 2-30 -alkenyl, C 2-30 -alkynyl, C 3-10 -cycloalkyl, C 5-10 -cycloalkenyl, C 8-10 -cycloalkynyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents R m , wherein R m is selected from the group consisting of a halogen, a —CN, a —NO 2 , a *═O, a —OH, a —NH 2 , a —NH(C 1-20 -alkyl), a —N(C 1-20 -alkyl) 2 , a —N(C 1-20 -alkyl)-C 6-14 -aryl, a —N(C 6-14 -aryl) 2 , a —S(O) m H, a —S(O) o —C 1-20 -alkyl, a —S(O) 2 OH, a —S(O) o —OC 1-20 -alkyl, a —S(O) o —OC 6-14 -aryl, a —CHO, a —C(O)—C 1-20 -alkyl, a —C(O)—C 6-14 -aryl, a —C(O)OH, a —C(O)—OC 1-20 -alkyl, a —C(O)—OC 6-14 -aryl, a —C(O)NH 2 , a —C(O)NH—C 1-20 -alkyl, a —C(O)N(C 1-20 -alkyl) 2 , a —C(O)NH—C 6-14 -aryl, a —C(O)N(C 1-20 -alkyl)-C 6-14 -aryl, a —C(O)N(C 6-14 -aryl) 2 , a —C(S)NH 2 , a —C(S)NH—C 1-20 -alkyl, a —C(S)N(C 1-20 -alkyl) 2 , a —C(S)N(C 6-14 -aryl) 2 , a —C(S)N(C 1-20 -alkyl)-C 6-14 -aryl, a —C(S)NH—C 6-14 -aryl, a —S(O) o NH 2 , a —S(O) o NH(C 1-20 -alkyl), a —S(O) o N(C 1-20 -alkyl) 2 , a —S(O) o NH(C 6-14 -aryl), a —S(O) o N(C 1-20 -alkyl)-C 6-14 -aryl, a —S(O) o N(C 6-14 -aryl) 2 , a SiH 3 , a SiH(C 1-20 -alkyl) 2 , a SiH 2 (C 1-20 -alkyl) and a Si(C 1-20 -alkyl) 3 ,
wherein o is an integer of 0, 1 or 2,
C 3-10 -cycloalkyl, C 5-10 -cycloalkenyl, —C 8-10 -cycloalkynyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents R n , wherein R n is selected from the group consisting of a C 1-20 -alkyl, a C 2-20 -alkenyl, a C 2-20 -alkynyl, a C 1-20 -alkoxy, a —S—C 1-20 -alkyl, and a C 1-20 -haloalkyl, and
Z 18 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,
or
L is
wherein
R 23 and R 24 are independently H, halogen, —CN, C 1-30 -alkyl, C 2-30 -alkenyl, C 2-20 -alkynyl, C 3-10 -cycloalkyl, C 5-10 -cycloalkenyl, C 8-10 -cycloalkynyl, C 1-30 -haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, —X 7 —R 25 , —X 8 —Ar 13 , —X 8 —Ar 14 —Ar 13 , —X 8 —Ar 14 —R 26 or —X 8 —Ar 14 —Ar 15 —R 26 ,
wherein
X 7 is —O—, —[Z 19 —O] c —, —[O—Z 19 ] c —O—, —S—, —[Z 19 —S—] c —, —[S—Z 19 ] c —S—, —S(O), —C(O)—, —C(O)O—, —C(O)NR 27 —, C(O)S—, —O(CO)—, —S(CO)—, —NR 27 C(O)— or —NR 27 —,
wherein
Z 19 is C 1-6 -alkylene, C 2-6 -alkenylene or C 1-6 -haloalkylene,
c is an integer of from 1 to 10, and
R 27 is H, C 1-20 -alkyl, or —Z 20 —C 6-14 -aryl,
wherein
Z 20 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,
R 25 is C 1-30 -alkyl, C 2-30 -alkenyl or C 1-30 -haloalkyl,
X 8 is —Z 21 —O—Z 22 , —Z 21 —S—Z 22 —, —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 28 , —C(O)S—, —O(CO)—, —S(CO)—, —NR 28 C(O)—, —NR 28 —, —Z 21 —SiR 28 2 —Z 22 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond,
wherein
Z 21 and Z 22 are C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and
R 28 is H, C 1-20 -alkyl, or —Z 23 —C 6-14 -aryl,
wherein
Z 23 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,
Ar 13 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 substituents R o , wherein R o is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,
Ar 14 and Ar 15 are C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R p , wherein R p is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and
R 26 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl, C 1-20 -alkoxy, —X 9 —Ar 16 , —X 9 —Ar 17 —Ar 16 , —X 9 —Ar 17 —R 29 , or X 9 —Ar 17 —Ar 18 —R 29 ,
wherein
X 9 is —Z 24 —O—Z 25 —, —Z 24 —S—Z 25 , —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 30 , —C(O)S—, —O(CO)—, —S(CO)—, —NR 30 C(O)—, —NR 30 —, —Z 24 —SiR 30 2 —Z 25 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond,
wherein
Z 24 and Z 25 are independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and
R 30 is H, C 1-20 -alkyl or —Z 26 —C 6-14 -aryl,
wherein
Z 26 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,
Ar 16 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R q , wherein R q is selected from the group consisting of a halogen, CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,
Ar 17 and Ar 18 are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R r , wherein R r is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and
R 29 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl or C 1-20 -alkoxy,
q and s are independently an integer of 0, 1, 2, 3, 4 or 5,
r is an integer of 0, 1 or 2, and
n is an integer of from 1 to 10,000.
2 . The compound of claim 1 , wherein A 1 and A 2 are S.
3 . The compound of claim 1 , wherein E is selected from the group consisting of
4 . The compound of claim 1 , wherein E is
5 . The compound of claim 1 , wherein E is
6 . The compound of claim 1 , wherein R 1 and R 2 are independently H, C 1-30 -alkyl, C 1-30 -haloalkyl, —X 1 —R 6 or —X 2 —Ar 1 ,
wherein
X 1 is —[Z 1 —O] a —, —[Z 1 —S—] a —, or —[S—Z 1 ] a —S—,
wherein
Z 1 is C 1-6 -alkylene or C 1-6 -haloalkylene, and
a is an integer of from 1 to 10,
R 6 is C 1-30 -alkyl or C 1-30 -haloalkyl,
X 2 is —Z 3 —O—Z 4 —, —Z 3 —S—Z 4 —, C 1-30 -alkylene or C 1-30 -haloalkylene,
wherein Z 3 and Z 4 are independently C 1-6 -alkylene or C 1-6 -haloalkylene,
and
Ar 1 is C 6-14 -aryl, optionally substituted with 1 to 5 substituents R a , wherein R a is selected from the group consisting of a halogen, a C 1-6 -alkyl, and a C 1-6 -alkoxy.
7 . The compound of claim 1 , wherein R 1 and R 2 are independently a C 1-30 -alkyl.
8 . The compound of claim 1 , wherein R 3 is —X 5 —Ar 7 , —X 5 —Ar 8 —Ar 7 , —X 5 —Ar 8 —R 13 or —X 5 —Ar 8 —Ar 9 —R 13 ,
wherein
X 5 is a covalent bond,
Ar 7 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R e , wherein R e is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,
Ar 8 and Ar 9 are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R f , wherein R f is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and
R 13 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl or C 1-20 -alkoxy.
9 . The compound of claim 1 , wherein R 3 is —X 5 —Ar 8 —R 13 ,
wherein
X 5 is a covalent bond,
Ar 8 is C 6-14 -arylene, and
R 13 is C 1-20 -alkyl.
10 . The compound of claim 1 , wherein G 1 and G 2 are independently a phenylene
or, a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue selected from the group consisting of
wherein phenylene or monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue are optionally substituted with 1 to 2 substituents R i , wherein R i is selected from the group consisting of a C 1-30 -alkyl, a —Z 17 —O—C 1-30 -alkyl, a —Z 17 —S—C 1-30 -alkyl, a —Z 17 —C 3-10 -cycloalkyl, a —Z 17 —C 6-14 -aryl, a —Z 17 -monovalent 3 to 12 membered aliphatic heterocyclic residue and a —Z 17 -monovalent 5 to 14 membered aromatic heterocyclic residue,
wherein
C 1-30 -alkyl, C 3-10 -cycloalkyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents wherein is independently selected from the group consisting of a halogen, a —CN and a *═O,
C 3-10 -cycloalkyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents R k , wherein R k is independently selected from the group consisting of a C 1-20 -alkyl, a C 1-20 -alkoxy, and a C 1-20 -haloalkyl,
and
Z 17 is C 1-6 -alkylene, C 1-6 -haloalkylene or a covalent bond.
11 . The compound of claim 1 , wherein G 1 and G 2 are independently a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue
which is substituted with 1 to 2 substituents R i , wherein R i is selected from the group consisting of a C 1-30 -alkyl and a —Z 17 —C 6-14 -aryl,
wherein
C 1-30 -alkyl and C 6-14 -aryl are optionally substituted with 1 to 4 substituents R j , wherein R j is selected from the group consisting of a halogen, a —CN and a *═O,
C 6-14 -aryl is optionally substituted with 1 to 4 substituents R k , wherein R k is selected from the group consisting of a C 1-20 -alkyl and a C 1-20 -alkoxy, and
Z 17 is a covalent bond.
12 . The compound of claim 1 , wherein R i is C 1-30 -alkyl.
13 . The compound of claim 1 , wherein
L is a bivalent 5 to 18 membered aromatic heterocyclic residue optionally substituted with 1 to 4 substituents R l , wherein R l is selected from the group consisting of a C 1-30 -alkyl, a —Z 18 —O—C 1-30 -alkyl, a —Z 18 —S—C 1-30 -alkyl, a —Z 18 —C 3-10 -cycloalkyl, a —Z 18 —C 6-14 -aryl, a —Z 18 -monovalent 3 to 12 membered aliphatic heterocyclic residue and a —Z 18 -monovalent 5 to 14 membered aromatic heterocyclic residue,
wherein
C 1-30 -alkyl, C 3-10 -cycloalkyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R m , wherein R m is selected from the group consisting of a halogen, a —CN and a *═O,
C 3-10 -cycloalkyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R n , wherein R n is selected from the group consisting of a C 1-20 -alkyl, a C 1-20 -alkoxy, and a C 1-20 -haloalkyl,
and
Z 18 is C 1-6 -alkylene, C 1-6 -haloalkylene or a covalent bond,
or L is
wherein R 23 and R 24 are independently H, halogen, —CN, C 1-30 -alkyl, C 2-30 -alkenyl, C 1-30 -haloalkyl, —X 7 —R 25 , —X 8 —Ar 13 , —X 8 —Ar 14 —Ar 13 , —X 8 —Ar 14 —R 26 or —X 8 —Ar 14 —Ar 15 —R 26 ,
wherein
X 7 is —O—, —[Z 19 —O] c —, —[O—Z 19 ] c —O—, —S—, —[Z 19 —S] c — or —[S—Z 19 ] c —S—,
wherein
Z 19 is C 1-6 -alkylene, C 2-6 -alkenylene or C 1-6 -haloalkylene, and
c is an integer of from 1 to 10,
R 25 is C 1-30 -alkyl, C 2-30 -alkenyl or C 1-30 -haloalkyl,
X 8 is Z 21 —O—Z 22 —, —Z 21 —S—Z 22 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond,
wherein Z 21 and Z 22 re independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,
Ar 13 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 substituents R o , wherein R o is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,
Ar 14 and Ar 15 are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R p , wherein R p is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and
R 26 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl or C 1-20 -alkoxy.
14 . The compound of claim 1 , wherein
L is a bivalent 5 to 18 membered aromatic heterocyclic residue selected from the group consisting of
wherein the bivalent 5 to 18 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents
wherein R l is selected from the group consisting of a C 1-30 -alkyl, a —Z 18 —O—C 1-30 -alkyl, a —Z 18 —S—C 1-30 -alkyl, a —Z 18 —C 3-10 -cycloalkyl, a —Z 18 —C 6-14 -aryl, a —Z 18 -monovalent 3 to 12 membered aliphatic heterocyclic residue and a —Z 18 -monovalent 5 to 14 membered aromatic heterocyclic residue,
wherein
C 1-30 -alkyl, C 3-10 -cycloalkyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R m , wherein R m is selected from the group consisting of a halogen, a —CN and a *═O,
C 3-10 -cycloalkyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R n , wherein R n is selected from the group consisting of a C 1-20 -alkyl, a C 1-20 -alkoxy, and a C 1-20 -haloalkyl, and
Z 18 is C 1-6 -alkylene, C 1-6 -haloalkylene or a covalent bond,
and
R t is hydrogen or C 1-30 -alkyl,
or
L is
wherein R 23 and R 24 are independently H, halogen, —CN, C 1-30 -alkyl, C 2-30 -alkenyl, C 1-30 -haloalkyl, —X 7 —R 25 , —X 8 —Ar 13 , —X 8 —Ar 14 —Ar 13 , —X 8 —Ar 14 —R 26 or —X 8 —Ar 14 —Ar 15 —R 26 ,
wherein
X 7 is —O—, —[Z 19 —O] c —, —[O—Z 19 ] c —O—, —S—, —[Z 19 —S—] c — or —[S—Z 19 ] c —S—,
wherein
Z 19 is C 1-6 -alkylene, C 1-6 -alkenylene or C 1-6 -haloalkylene, and
c is an integer of from 1 to 10,
R 25 is C 1-30 -alkyl, C 2-30 -alkenyl or C 1-30 -haloalkyl,
X 8 is —Z 21 —O—Z 22 —, —Z 21 —S—Z 22 —, C 1-30 -alkylene, C 1-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond,
wherein Z 21 and Z 22 are independently C 1-6 -alkylene, C 1-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,
Ar 13 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 substituents R o , wherein R o is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,
Ar 14 and Ar 15 are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R p , wherein R p is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and
R 26 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl or C 1-20 -alkoxy.
15 . The compound of claim 1 , wherein
L is
wherein R 1 is selected from the group consisting of a C 1-30 -alkyl, a —Z 18 —O—C 1-30 -alkyl, a —Z 18 —S—C 1-30 -alkyl, a —Z 18 —C 3-10 -cycloalkyl, a —Z 18 —C 6-14 -aryl, a —Z 18 -monovalent 3 to 12 membered aliphatic heterocyclic residue and a —Z 18 -monovalent 5 to 14 membered aromatic heterocyclic residue.
wherein
C 1-30 -alkyl, C 3-10 -cycloalkyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R m , wherein R m is selected from the group consisting of a halogen, a —CN and a *═O,
C 3-10 -cycloalkyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R n , wherein R n is selected from the group consisting of a C 1-20 -alkyl, a C 1-20 -alkoxy, and a C 1-20 -haloalkyl, and
Z 18 is C 1-6 -alkylene, C 1-6 -haloalkylene or a covalent bond,
or
L is
wherein R 23 and R 24 are independently H, halogen, —CN, C 1-30 -alkyl, C 2-30 -alkenyl, C 1-30 -haloalkyl, —X 7 —R 25 , —X 8 —Ar 13 , —X 8 —Ar 14 —Ar 13 , —X 8 —Ar 14 —R 26 or —X 8 —Ar 14 —Ar 15 —R 26 ,
wherein
X 7 is —O—, —[Z 19 —O] c —, —[O—Z 19 ] c —O—, —S—, —[Z 19 —S—] c — or —[S—Z 19 ] c —S—,
wherein
Z 19 is C 1-6 -alkylene, C 2-6 -alkenylene or C 1-6 -haloalkylene, and
c is an integer of from 1 to 10,
R 25 is C 3-30 -alkyl, C 2-30 -alkenyl or C 1-30 -haloalkyl.
X 8 is Z 21 —O—Z 22 —, —Z 21 —S—Z 22 —, C 1-30 -alkylene, C 1-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond,
wherein Z 21 and Z 22 are independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,
Ar 13 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 substituents R o , wherein R o is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,
Ar 14 and Ar 15 are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R p , wherein R p is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and
R 26 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl or C 1-20 -alkoxy.
16 . The compound of claim 1 , wherein
R l is selected from the group consisting of a C 1-30 -alkyl and a —Z 18 —C 6-14 -aryl,
wherein
C 1-30 -alkyl and C 6-14 -aryl are optionally substituted with 1 to 4 substituents R m , wherein R m is selected from the group consisting of a halogen, a —CN and a *═O,
C 6-14 -aryl is optionally substituted with 1 to 4 substituents R n , wherein R n is selected from the group consisting of a C 1-20 -alkyl and a C 1-20 -alkoxy, and
Z 18 is a covalent bond,
and R 23 and R 24 are independently H, C 1-30 -alkyl, C 1-30 -haloalkyl, —X 7 —R 25 or —X 8 —Ar 13 ,
wherein
X 7 is —[Z 19 —O] c —, —[Z 19 —S—] c —, or —[S—Z 19 ] c —S—,
wherein
Z 19 is C 1-6 -alkylene or C 1-6 -haloalkylene, and
c is an integer of from 1 to 10,
R 25 is C 1-30 -alkyl or C 1-30 -haloalkyl,
X 8 is —Z 21 —O—Z 22 —, —Z 21 —S—Z 22 —, C 1-30 -alkylene or C 1-30 -haloalkylene,
wherein Z 21 and Z 22 are independently C 1-6 -alkylene or C 1-6 -haloalkylene,
and
Ar 13 is C 6-14 -aryl, optionally substituted with 1 to 5 substituents R o , wherein R o is selected from the group consisting of a halogen C 1-6 -alkyl and a C 1-6 -alkoxy.
17 . The compound of claim 1 , wherein R l is C 1-30 -alkyl,
and R 23 and R 24 are independently H, C 1-30 -alkyl or C 1-30 -haloalkyl.
18 . The compound of claim 1 , wherein q, r and s are an integer of 0 or 1, and q, r and s are not all 0 at the same time.
19 . The compound of claim 1 , wherein n is an integer of from 1 to 5000.
20 . An electronic device comprising the compound of claim 1 .
21 . The electronic device of claim 20 , wherein the electronic device is an organic field effect transistor.
22 . An organic semiconducting material comprising the compound of claim 1 .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.